Skip to main content

Retroviral/Lentiviral Transduction and Transformation Assay

  • Protocol
  • First Online:
Leukemia

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 538))

Summary

Non-random chromosomal translocations can be found in about half of acute leukaemia patients and mostly lead to either over-expression of proto-oncogenes or creation of novel fusion genes. To assess the oncogenic potential and characterize the underlying mechanisms mediated by these candidate oncoproteins, a retroviral transduction/transformation assay (RTTA) has been successfully employed to study the biological impacts of a number of proto-oncoproteins and novel fusion proteins in primary hematopoietic cells both in vitro and in vivo. To further widen the application of the RTTA, a lentiviral transduction/transformation assay (LTTA) has also been developed to target the most quiescent hematopoietic stem cells (HSCs). This chapter will cover both the RTTA and LTTA for studying candidate oncogenes involved in human leukaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Look, A. T. (1997) Oncogenic transcription factors in the human acute leukemias. Science 278(5340), 1059–64.

    Article  PubMed  CAS  Google Scholar 

  2. Greaves, M. (2003) Pre-natal origins of childhood leukemia. Rev. Clin. Exp. Hematol. 7(3), 233–45.

    PubMed  CAS  Google Scholar 

  3. Rabbitts, T. H., Appert, A., Chung, G., et al (2001) Mouse models of human chromosomal translocations and approaches to cancer therapy. Blood Cells Mol. Dis. 27(1), 249–59.

    Article  PubMed  CAS  Google Scholar 

  4. Forster, A., Pannell, R., Drynan, L. F., et al (2003) Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell 3(5), 449–58.

    Article  PubMed  CAS  Google Scholar 

  5. Lavau, C., Szilvassy. S. J., Slany. R., and Cleary. M. L. (1997) Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16(14), 4226–37.

    Article  PubMed  CAS  Google Scholar 

  6. So, C. W., and Cleary, M. L. (2002) MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell. Biol. 22(18), 6542–52.

    Article  PubMed  CAS  Google Scholar 

  7. Cozzio, A., Passegue, E., Ayton, P. M., Karsunky, H., Cleary, M. L., and Weissman, I. L. (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17(24), 3029–35.

    Article  PubMed  CAS  Google Scholar 

  8. So, C. W., Karsunky, H., Passegue, E., Cozzio, A., Weissman, I. L., and Cleary, M. L. (2003) MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 3(2), 161–71.

    Article  PubMed  CAS  Google Scholar 

  9. Zufferey, R., Dull, T., Mandel, R. J., et al (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72(12), 9873–80.

    PubMed  CAS  Google Scholar 

  10. Dull, T., Zufferey, R., Kelly, M., et al (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72(11), 8463–71.

    PubMed  CAS  Google Scholar 

  11. Kogan, S. C., Ward, J. M., Anver, M. R., et al (2002) Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100(1), 238–45.

    Article  PubMed  CAS  Google Scholar 

  12. Morse, H. C. III, Anver, M. R., Fredrickson, T. N., et al (2002) Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100(1):246–58.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors would like to thank Amanda Wilson, Jenny Yeung, and other members of the So’s lab for constructive advice. This work was supported by the Association for International Cancer Research (AICR), Cancer Research UK, the Kay Kendall Leukaemia Fund, Medical Research Council, Wellcome Trust, and Leukaemia Research Fund. Eric So is an AICR fellow and an EMBO young investigator.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chi Wai Eric So .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Zeisig, B.B., Wai Eric So, C. (2009). Retroviral/Lentiviral Transduction and Transformation Assay. In: Eric So, C.W. (eds) Leukemia. Methods in Molecular Biology™, vol 538. Humana Press. https://doi.org/10.1007/978-1-59745-418-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-418-6_10

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-989-5

  • Online ISBN: 978-1-59745-418-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics